Domenico Gabrielli

Chief

Azienda Ospedaliera San Camillo-Forlanini

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Domenico Gabrielli is a Chief at Azienda Ospedaliera San Camillo-Forlanini in Italy. His research focuses on cardiovascular health, cardio-oncology, and the interplay between metabolic syndrome and cancer treatment outcomes. Recent publications include topics on the cardioprotective effects of pharmacological interventions and management strategies for complex cardiovascular conditions in cancer patients.

Articles (9)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2021

Collaborators (4)

Christian Cadeddu Dessalvi

University of Cagliari

ITALY

View details

Michele Caraglia

Full Professor of Biochemistry

Università degli Studi della Campania Luigi Vanvitelli

ITALY

View details

Massimo Imazio

ITALY

View details

Celeste Fonderico

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Domenico Gabrielli

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition

In the Era of Cardiovascular–Kidney–Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy

Colchicine and Atherosclerotic Coronary Artery Disease: An Updated Review

Unveiling Functional Impairment in Fabry Disease: The Role of Peripheral vs. Cardiac Mechanisms

Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism

Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients

The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients

Recent Advances and Future Directions in Syncope Management: A Comprehensive Narrative Review

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events

Collaborators (4)

Christian Cadeddu Dessalvi

Michele Caraglia

Massimo Imazio

Celeste Fonderico

Make your next move.